According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $3.50. In 2022 the company made an earnings per share (EPS) of $8.48 an increase over its 2021 EPS that were of $2.99.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $3.50 | -58.72% |
2022 | $8.48 | 183.39% |
2021 | $2.99 | -17.83% |
2020 | $3.64 | 21.82% |
2019 | $2.99 | 23.91% |
2018 | $2.41 | 141.48% |
2017 | $1.00 | 64.6% |
2016 | $0.61 | -90.64% |
2015 | $6.48 | 178.14% |
2014 | $2.33 | -48.16% |
2013 | $4.50 | 22.63% |
2012 | $3.67 | -11.32% |
2011 | $4.14 | 230.25% |
2010 | $1.25 | -70.98% |
2009 | $4.32 | 6.76% |
2008 | $4.04 | -15.14% |
2007 | $4.76 | 7.82% |
2006 | $4.42 | 19.61% |
2005 | $3.69 | 18.56% |
2004 | $3.12 | 0.36% |
2003 | $3.10 | 50.39% |
2002 | $2.06 | 31.13% |
2001 | $1.57 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Novartis NVS | $3.74 | 6.84% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | -46.87% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | -9.15% | ๐ซ๐ท France |
Merck MRK | $1.82 | -47.96% | ๐บ๐ธ USA |
AstraZeneca AZN | $1.98 | -43.30% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | -$2.00 | -157.13% | ๐ฎ๐ฑ Israel |
Dynavax Technologies
DVAX | $0.87 | -75.15% | ๐บ๐ธ USA |